H-TSYKFESV-OH
Ref. 3D-PP43506
1mg | 202,00 € | ||
10mg | 234,00 € | ||
100mg | 412,00 € |
Información del producto
- NH2-Thr-Ser-Tyr-Lys-Phe-Glu-Ser-Val-OH
Peptide H-TSYKFESV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TSYKFESV-OH include the following: Antiviral protection following immunization correlates with humoral but not cell-mediated immunity V Panchanathan, G Chaudhri - Immunology and cell , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1038/icb.2009.110 Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion T Frenz, Z Waibler, J Hofmann - European journal of , 2010 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.201040453 A novel naturally occurring tandem promoter in modified vaccinia virus ankara drives very early gene expression and potent immune responses ST Wennier, K Brinkmann, C Steinhausser - PLoS , 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0073511 Cutting edge: protection by antiviral memory CD8 T cells requires rapidly produced antigen in large amounts S Remakus, X Ma, L Tang, RH Xu - The Journal of , 2018 - journals.aai.orghttps://journals.aai.org/jimmunol/article/200/10/3347/106655 Gamma Interferon and Perforin Control the Strength, but Not the Hierarchy, of Immunodominance of an Antiviral CD8+ T Cell Response S Remakus, LJ Sigal - Journal of virology, 2011 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.05334-11 Memory CD8+ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection S Remakus, D Rubio, A Lev, X Ma, M Fang, RH Xu - Cell host & , 2013 - cell.comhttps://www.cell.com/cell-host-microbe/pdf/S1931-3128(13)00124-8.pdf Direct Presentation Is Sufficient for an Efficient Anti-Viral CD8+ T Cell Response RH Xu, S Remakus, X Ma, F Roscoe, LJ Sigal - PLoS pathogens, 2010 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1000768 Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2 MS Rolph, TR Young, BOV Shum - The Journal of , 2006 - journals.aai.orghttps://journals.aai.org/jimmunol/article/177/11/7794/73841 Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming MD Gainey, JG Rivenbark , H Cho - Proceedings of the , 2012 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1217111109 Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox M Kremer, Y Suezer, A Volz, T Frenz, M Majzoub - PLoS , 2012 - journals.plos.orghttps://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1002557 The generation of CD8+ T-cell population specific for vaccinia virus epitope involved in the antiviral protection against ectromelia virus challenge M Gierynska, L Szulc-Dabrowska - FEMS Pathogens , 2015 - academic.oup.comhttps://academic.oup.com/femspd/article-abstract/73/9/ftv088/2467622 CD4+ T Cell Help Is Dispensable for Protective CD8+ T Cell Memory against Mousepox Virus following Vaccinia Virus Immunization M Fang, S Remakus, F Roscoe, X Ma - Journal of , 2015 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.02176-14 CD94 is essential for NK cell-mediated resistance to a lethal viral disease M Fang, MT Orr, P Spee, T Egebjerg, LL Lanier - Immunity, 2011 - cell.comhttps://www.cell.com/immunity/pdf/S1074-7613(11)00053-7.pdf Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute K Baur, K Brinkmann, M Schweneker - Journal of , 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00604-10 Structural and functional correlates of enhanced antiviral immunity generated by heteroclitic CD8 T cell epitopes JA Trujillo , S Gras , KA Twist, NP Croft - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/192/11/5245/92498 A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human IM Belyakov, D Isakov, Q Zhu, A Dzutsev - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/11/7211/42997 Natural killer cells and innate interferon gamma participate in the host defense against respiratory vaccinia virus infection G Abboud, V Tahiliani , P Desai , K Varkoly - Journal of , 2016 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01894-15 Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8+ T cell-mediated, TNF-dependent immunopathology F Liu, R Feuer, DE Hassett - The Journal of clinical , 2006 - Am Soc Clin Investighttps://www.jci.org/articles/view/25608 Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses CF Towne, IA York , LB Watkin , JS Lazo - The Journal of , 2007 - journals.aai.orghttps://journals.aai.org/jimmunol/article/178/11/6923/42998 Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections CF Towne, IA York , J Neijssen , ML Karow - The Journal of , 2008 - journals.aai.orghttps://journals.aai.org/jimmunol/article/180/3/1704/75825 Resistance to poxvirus lethality does not require the necroptosis proteins RIPK3 or MLKL B Montoya, CJ Knudson, CR Melo-Silva - Journal of , 2023 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01945-22
Propiedades químicas
Consulta técnica sobre: 3D-PP43506 H-TSYKFESV-OH
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.